EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Short Interest Update

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) was the target of a large decrease in short interest during the month of June. As of June 30th, there was short interest totaling 39,841 shares, a decrease of 79.3% from the June 15th total of 192,041 shares. Based on an average daily trading volume, of 280,156 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the shares of the stock are short sold.

EssilorLuxottica Trading Down 0.3%

Shares of OTCMKTS:ESLOY traded down $0.27 during trading on Friday, hitting $97.79. 61,664 shares of the company were exchanged, compared to its average volume of 111,231. EssilorLuxottica has a 1-year low of $91.57 and a 1-year high of $186.81. The company has a quick ratio of 0.70, a current ratio of 0.99 and a debt-to-equity ratio of 0.17. The business’s 50 day moving average is $100.52 and its 200-day moving average is $123.90.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Zacks Research cut EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research report on Tuesday, June 23rd. Deutsche Bank Aktiengesellschaft assumed coverage on shares of EssilorLuxottica in a report on Tuesday, May 12th. They issued a “hold” rating for the company. Two analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

EssilorLuxottica Company Profile

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.